Bromhexine, Guaifenesin Combination: There are no adequate and well-controlled clinical studies in pregnant or breastfeeding women for the combination of bromhexine and guaifenesin.
Bromhexine: Pregnancy: Bromhexine passes the placental barrier. Animal studies have not shown any direct or indirect negative effect on pregnancy, development of the fetus, the delivery or postnatal development.
Up to now, clinical experience has not given any evidence for adverse effects on the fetus during pregnancy. However, normal caution should be used when use of drugs during pregnancy.
Especially during the first trimester, bromhexine should be avoided.
Lactation: Bromhexine is excreted into breast milk. Bromhexine is not recommended during lactation, inspite of the fact that no adverse effects in breastfed children can be expected.
Guaifenesin: There are no adequate and well-controlled studies in pregnant or breastfeeding women for guaifenesin.
This product should not be used during pregnancy or lactation unless the potential benefit of treatment to the mother outweighs the possible risks to the developing fetus or nursing infant. Ask a physician before use if the patient is pregnant or breastfeeding.
Other Services
Country
Account